Alzheimer’s Disease Neuroimaging Initiative

4453 Total Publications

Year	Title	Author	Journal
2013	CSF alpha-synuclein improves diagnostic and prognostic performance of CSF tau and Abeta in Alzheimer’s disease.	Toledo, J. B., Korff, A., Shaw, L. M., Trojanowski, J. Q., & Zhang, J.	Journal Acta Neuropathologica;
2013	Sample size estimates for well-powered cross-sectional cortical thickness studies.	Pardoe, H. R., Abbott, D. F., Jackson, G. D., & Initiative, A. D. N.	Journal Human Brain Mapping;
2013	α-Synuclein in cerebrospinal fluid of Alzheimer’s disease and mild cognitive impairment.	Ane Korff, PhD, Changqin Liu, MD, PhD, Carmen Ginghina, MD, Min Shi, PhD, and Jing Zhang, MD, PhD, for the Alzheimer’s Disease Neuroimaging Initiative	Journal Journal of Alzheimer's Disease;
2013	Latent feature representation with stacked auto-encoder for AD/MCI diagnosis.	Suk, H.-I., Lee, S.-W., & Shen, D.	Journal Brain Structure and Function;
2013	Gaussian mixture model-based noise reduction in resting state fMRI data.	Garg, G., Prasad, G., & Coyle, D.	Journal Journal of Neuroscience Methods;
2013	Regional patterns of atrophy on MRI in Alzheimer’s disease: Neuropsychological features and progression rates in the ADNI cohort.	Duara, R., Loewenstein, D. a., Shen, Q., Barker, W., Greig, M. T., Varon, D., … Dickson, D. W.	Journal Advances in Alzheimer's Disease;
2013	Higher rates of decline for women and apolipoprotein E epsilon4 carriers.	Holland, D., Desikan, R. S., Dale, a M., & McEvoy, L. K.	Journal American Journal of Neuroradiology;
2013	White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.	Guzman, V. a., Carmichael, O. T., Schwarz, C., Tosto, G., Zimmerman, M. E., & Brickman, A. M.	Journal Alzheimer's and Dementia;
2013	Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer’s disease and mild cognitive impairment.	Westman, E., Aguilar, C., Muehlboeck, J.-S., & Simmons, A.	Journal Brain Topography;
2013	Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer’s disease.	Guo, L.-H., Alexopoulos, P., & Perneczky, R.	Journal European Archives of Psychiatry and Clinical Neuroscience;